Recent

% | $
Quotes you view appear here for quick access.

Hemispherx Biopharma, Inc. Message Board

  • mogoat24 mogoat24 Jun 8, 2009 10:47 AM Flag

    Overdramatic rejection! I dont think so

    Why would the FDA draw this out so long and create such a huge hoopla by doing so, articles, conferences, blogs etc... all talking about this stock. For a simple rejection?

    HEB has been the talk of the bio-pharm investment world for about 3 weeks now.

    Makes me wonder, by drawing this out - they increase scrutiny on themselves (the FDA) why do so, if they could have put this to bed about 2 weeks ago - without any noise???

    Perhaps, I am just too optimistic, but you have to remember that the FDA is part of the government, a new presidential administration, is always looking for ways to minimize public scrutiny. I certainly believe they didnt draw this out to simply reject it and raise a ruckus...

    Perhaps my thought is ridiculous...but i cant help think about it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
HEB
0.1155-0.0045(-3.75%)Jun 24 4:02 PMEDT